The Trip Report
A podcast by Beckley Waves - Thursdays
Categories:
34 Episodes
-
#32 Rachelle Sampson & Bennet Zelner: The Connected Leadership Study
Published: 9/19/2024 -
Ep #31 Rebecca Kronman: Psychedelics & Parenting
Published: 9/5/2024 -
Ep #30 Nick Gillespie: Reflection on the FDA’s Rejection of MDMA Assisted Therapy
Published: 8/22/2024 -
Special Dispatch: FDA Rejects Lykos’ MDMA Assisted Therapy Application
Published: 8/13/2024 -
#29 Dr. Selma Holden MD: All Eyes on the FDA
Published: 8/8/2024 -
#28 East Forest: Music for Mushrooms
Published: 7/25/2024 -
#27 Joanna Kempner: Psychedelic Outlaws
Published: 7/11/2024 -
#26 Brandon Kapelow: ‘An Act of Service’- A Journey Through PTSD and Ketamine Therapy
Published: 6/27/2024 -
#25 Christof Koch: Exploring Consciousness and Perception
Published: 6/13/2024 -
#24 Manesh Girn Ph.D. - Exploring the Psychedelic Brain and Human Potential
Published: 5/30/2024 -
#23 Dennis Walker: The Court Jester of Psychedelics
Published: 5/16/2024 -
#22 Bruce Damer: Catalyzing Scientific and Creative Breakthroughs
Published: 5/2/2024 -
#21: Pedro Teixeira, Ph.D. - Psychedelics and Health Behavior Change
Published: 4/18/2024 -
#20: Jackie von Salm, Ph.D. - Natural Products & Novel Therapies
Published: 4/4/2024 -
#19 Beckley Academy: Charting the Course for Psychedelic-Assisted Therapy
Published: 3/21/2024 -
#18 Rick Doblin: The Path to MDMA Approval and Beyond
Published: 3/7/2024 -
#17: Marcus Capone: Psychedelic Access for Veterans
Published: 2/22/2024 -
#16: Greg Kubin: The Varieties of Mental Health Innovation
Published: 2/8/2024 -
#15: Brandon Deroche: How Social Movements Form and Grow
Published: 1/25/2024 -
#14: Ken Jordan: The Case for Optimism
Published: 1/11/2024
The Trip Report is a podcast and newsletter about the business, science, and policy developments of the evolving psychedelic field. While the main organizing theme is psychedelics, it is really about the many different domains that are converging to bring about this field and the assembly of what many believe to be a “New Paradigm” in science, medicine, and our understanding of the human experience. Our goal is to foster an educated and informed psychedelic ecosystem, and to do that, we will feature in-depth conversations with scientists, entrepreneurs, investors and stakeholders at the forefront of the psychedelic renaissance. www.thetripreport.com